Pharmaceutical Industry Articles & Reports

A 2026 analyst census of pharma AI hiring trends covering 11 top drugmakers AI leadership hires, job titles, salary benchmarks, and the M&A and layoffs backdrop shaping the talent market.

An analysis of EMA and HMA's 2025 AI Observatory report, covering Scientific Explorer's March 2026 expansion, the NDSG 2026-2028 workplan, EU AI Act timelines, and pharmacovigilance AI governance as of 2026.

A 2026 analyst review of FDA Operation TrialBlazer and the proposed Expedited IND pilot, covering Qualified Research Institutions, the 30-day IND clock, CMC guidance, eligibility, and open comment-period questions.

A 2026 analyst ranking of the top pharma cold chain logistics companies, covering DHL, UPS Healthcare, FedEx, Kuehne+Nagel, Cryoport, Envirotainer, market size data, and GDP/IATA CEIV Pharma certification standards.

A 2026 analyst ranking of the top 15 generic drug companies by revenue, covering Sandoz, Teva, Viatris, Sun Pharma and Indian majors, global market size data, and regional market share.

A 2026 analyst comparison of the top 10 single-use bioreactor manufacturers, covering Sartorius, Thermo Fisher, Cytiva, Merck KGaA, and Eppendorf, with scale ranges, market share data, and single-use vs stainless-steel cost analysis.

Ranks and profiles the top 15 US biotech incubators and accelerators for 2026, comparing funding and equity terms, lab space models, university affiliated programs, and AI drug discovery venture accelerators.

A 2026 analyst comparison of 8 pharmaceutical stability chamber manufacturers including Binder, Memmert, Thermo Fisher, Weiss Technik, and ESPEC, covering ICH Q1A(R2) conditions, walk-in room sizing, and market data.

A 2026 analyst comparison of the top HPLC system manufacturers including Waters, Agilent, Thermo Fisher, and Shimadzu, covering UHPLC pressure specs up to 1,500 bar, CDS software options, and market size data from six research firms.

A 2026 analyst comparison of the top lyophilization CDMOs, including Catalent, Lonza, Simtra, Vetter, and PCI Pharma Services, covering freeze-dryer capacity, sterile fill-finish specs, recent capacity investments, and how to choose a partner.

A 2026 analyst ranking of the top 10 sterile fill-finish CDMOs, covering isolator vs RABS technology, prefilled syringe capacity, EU Annex 1 compliance, and capital investment data for Lonza, Thermo Fisher, Catalent, and more.

A 2026 analyst ranking of the top 10 mass spectrometry manufacturers, covering Thermo Fisher, Agilent, Waters, Bruker, and Shimadzu, with market size data, revenue figures, and proteomics platform benchmarks.

A 2026 comparison of the top 10 electronic lab notebook (ELN) platforms, covering Benchling, LabArchives, SciNote, and Dotmatics, with pricing, 21 CFR Part 11 compliance, and free ELN options.

A 2026 analyst ranking of the top CDMO companies by revenue and capacity, covering Lonza, Samsung Biologics, WuXi Biologics, and Thermo Fisher, plus CDMO vs CMO vs CRO differences and $150B+ market data.

A 2026 analyst comparison of Illumina vs Thermo Fisher Ion Torrent NGS platforms, covering SBS vs ion semiconductor chemistry, accuracy benchmarks, cost per sample, clinical oncology use, and market share.

A 2026 analyst guide to pharmaceutical formulation development covering preformulation studies, BCS classification, solubility and bioavailability enhancement techniques, ICH Q1A(R2) stability testing, and five named case studies.

A 2026 analyst comparison of ADC CDMOs including Lonza, WuXi XDC, Catalent, Piramal, Abzena, and CordenPharma, covering conjugation capacity, HPAPI containment (OEB/OEL), and capital investment data.

A 2026 analyst guide to private LLM total cost of ownership in pharma: on-prem GPU capex, API pricing, GxP validation costs, break-even analysis, and five named deployments from Lilly, Roche, BMS, Amgen, and J&J.

A 2026 analyst guide to parenteral drug products, covering IV, IM and SC routes, vials versus prefilled syringes, autoinjectors and wearable injectors, and FDA and EU combination product rules.

2026 analyst comparison of ISO 14644-1 cleanroom classes and EU GMP Annex 1 Grades A-D, covering particle limits, viable-monitoring CFU limits, requalification cadence, and four named FDA enforcement and industry cases.

A 2026 analyst guide to dissolution testing and bioequivalence, covering f2 similarity factor calculation and its statistical limitations, USP apparatus types, BCS biowaiver rules under FDA, EMA, WHO and ICH M9, and IVIVC modeling.

A 2026 analyst guide to pharmaceutical excipients: FDA/EMA definitions, the 10 functional categories, drug-excipient compatibility testing methods, the FDA Novel Excipient Review Pilot Program, and a $10.7-11.0 billion market analysis.

Compares terminal sterilization and aseptic processing in pharmaceutical manufacturing as of 2026: SAL 10-6 vs 10-3, FDA/EMA/Annex 1 rules, USP 71 limits, market data, and 5 named cases.

A 2026 analyst comparison of clinical trial software covering CTMS, EDC, eTMF, eConsent, eCOA, and payments platforms including Veeva, Medidata, Oracle, IQVIA, Castor, Advarra, REDCap, and Signant Health, with pricing, market data, and FDA case studies.